Efficacy and safety of the triple combination cream in Chinese patients with moderate to severe melasma: A multi-center, randomized, double-blind, three-arm, parallel-group, placebo-controlled clinical trial

Authors

Chao Ji (ORCID: https://orcid.org/0000-0002-2282-3505)
Quan‐Zhong Liu (ORCID: https://orcid.org/0000-0002-7389-7918)
Weili Pan
Lunfei Liu (ORCID: https://orcid.org/0000-0003-3200-4279)
Xing‐Hua Gao (ORCID: https://orcid.org/0000-0001-8809-8564)
Linfeng Li (ORCID: https://orcid.org/0000-0002-6580-5024)
Li Zhang (ORCID: https://orcid.org/0000-0003-1620-1512)
Jinyan Wang
Hao Cheng (ORCID: https://orcid.org/0000-0001-5089-6747)
Geyao Xu
Meng Pan (ORCID: https://orcid.org/0000-0003-4947-9369)

Institutions

Fujian Medical University (CN)
IHI Corporation (United States) (US)
Capital Medical University (CN)
Ruijin Hospital (CN)
Sir Run Run Shaw Hospital (CN)
Tianjin Medical University General Hospital (CN)
Ningbo No. 2 Hospital (CN)
First Affiliated Hospital of Fujian Medical University (CN)
Zhejiang Provincial People's Hospital (CN)
First Hospital of China Medical University (CN)
Beijing Friendship Hospital (CN)
Zhejiang University (CN)
China Medical University (CN)

Publication Details

Journal: Chinese Medical Journal
Published: 2025-09-16
DOI: https://doi.org/10.1097/cm9.0000000000003718
Primary Topic: Dermatologic Treatments and Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Efficacy and safety of the triple combination cream in Chinese patients with moderate to severe melasma: A multi-center, randomized, double-blind, three-arm, parallel-group, placebo-controlled clinical trial

Chao Ji, Quan‐Zhong Liu, Weili Pan, Lunfei Liu et al.

Sep 16, 2025

Chinese Medical Journal

Dermatologic Treatments and Research

article

Efficacy and safety of the triple combination cream in Chinese patients with moderate to severe melasma: A multi-center, randomized, double-blind, three-arm, parallel-group, placebo-controlled clinical trial

Chao Ji, Quan‐Zhong Liu, Weili Pan, Lunfei Liu, Xing‐Hua Gao, Linfeng Li, Li Zhang, Jinyan Wang, Hao Cheng, Geyao Xu, Meng Pan

September 16, 2025article en

Abstract

No abstract available for this paper.

Chinese Medical JournalVol. 139(6)

Fujian Medical University (CN), IHI Corporation (United States) (US), Capital Medical University (CN), Ruijin Hospital (CN), Sir Run Run Shaw Hospital (CN), Tianjin Medical University General Hospital (CN), Ningbo No. 2 Hospital (CN), First Affiliated Hospital of Fujian Medical University (CN), Zhejiang Provincial People's Hospital (CN), First Hospital of China Medical University (CN), Beijing Friendship Hospital (CN), Zhejiang University (CN), China Medical University (CN)

Openalex Percentile: Top 55%

Dermatologic Treatments and Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy and safety of the triple combination cream in Chinese patients with moderate to severe melasma: A multi-center, randomized, double-blind, three-arm, parallel-group, placebo-controlled clinical trial — Chao Ji, Quan‐Zhong Liu, et al. · Chinese Medical Journal (2025) | TGRS Research Map | TGRS